Arcadia Biosciences, Inc. 4

Accession 0001209191-15-070253

$RKDACIK 0001469443operating

View on SEC.gov Company Profile

Filed

Sep 9, 8:00 PM ET

Accepted

Sep 10, 8:12 PM ET

Size

20.9 KB

Accession

0001209191-15-070253

Insider Transaction Report

Form 4

Period: 2015-09-08

Arcadia Biosciences, Inc.RKDA

Lu Zhongjin

VP Product Development

Transactions

Exercise/Conversion
Common Stock
2015-09-08$0.44/sh+8,882$3,908→ 8,882 total
Exercise/Conversion
Common Stock
2015-09-10$0.44/sh+3,685$1,621→ 14,172 total
Exercise/Conversion
Employee Stock Option (right to buy)
2015-09-10−3,685→ 2,958 total
Exercise: $0.44Exp: 2015-12-31→ Common Stock (3,685 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2015-09-09−6,975→ 6,643 total
Exercise: $0.44Exp: 2015-12-31→ Common Stock (6,975 underlying)
Sale
Common Stock
2015-09-08$5.51/sh−3,000$16,527→ 5,882 total
Sale
Common Stock
2015-09-09$5.55/sh−2,370$13,144→ 10,487 total
Sale
Common Stock
2015-09-10$5.27/sh−1,302$6,863→ 12,870 total
Exercise/Conversion
Common Stock
2015-09-09$0.44/sh+6,975$3,069→ 12,857 total
Exercise/Conversion
Employee Stock Option (right to buy)
2015-09-08−8,882→ 13,618 total
Exercise: $0.44Exp: 2015-12-31→ Common Stock (8,882 underlying)

Footnotes (5)

[F1]The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan (the "Plan"), adopted by the Reporting Person on June 14, 2015. Pursuant to the Plan and in compliance with the Issuer's IPO Lock-up Agreements with Credit Suisse Securities (USA) ("CSSU"), the Reporting Person paid the exercise price and CSSU sold shares only to satisfy the tax liability and costs. The balance of the shares will be held until the expiration of the IPO Lock-up Agreements.
[F2]This transaction was executed in multiple trades at prices ranging from $5.28 to $5.67. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
[F3]This transaction was executed in multiple trades at prices ranging from $5.33 to $5.73. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F4]This transaction was executed in multiple trades at prices ranging from $5.10 to $5.76. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F5]The option is fully exercisable as of the date hereof.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Arcadia Biosciences, Inc.

CIK 0001469443

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0001469443

Filing Metadata

Form type: 4
Filed: Sep 9, 8:00 PM ET
Accepted: Sep 10, 8:12 PM ET
Size: 20.9 KB

View on SEC.gov